Pancreatic Cancer Research

ResearcherKyoto UniversityActive in the last 2 years

Masayuki Ueno

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2497-9327; OpenAlex author ID A5083177175. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
39
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers · 2026: 2 papers

Papers 5

  1. Mortality and cancer risk in patients with chronic pancreatitis in japan: insights into the importance of surveillance for pancreatic cancer. Co-author DOI 10.1007/s00535-025-02321-0↗
  2. Stroke in Patients With Unresectable Pancreatic Cancer Undergoing Chemotherapy: Clinical Characteristics and Risk Assessment. First author DOI 10.1097/mpa.0000000000002555↗
  3. Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of trea… Co-author DOI 10.1007/s00535-024-02186-9↗
  4. Correction: Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probabi… Co-author DOI 10.1007/s00535-025-02215-1↗
  5. A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer. Co-author DOI 10.1093/annonc/mdv603↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masafumi Ikeda · 3 shared papers, 2016–2025 · strength 0.37
  2. Junji Furuse · 3 shared papers, 2016–2025 · strength 0.37
  3. Akinori Asagi · 2 shared papers, 2025 · strength 0.32
  4. Yohei Kitano · 2 shared papers, 2025 · strength 0.32
  5. Nana Kimura · 2 shared papers, 2025 · strength 0.32
  6. Kunihiro Tsuji · 2 shared papers, 2025 · strength 0.32
  7. Kumiko Umemoto · 2 shared papers, 2025 · strength 0.32
  8. Takeshi Terashima · 2 shared papers, 2025 · strength 0.32
  9. Satoshi Kobayashi · 2 shared papers, 2025 · strength 0.32
  10. Rei Suzuki · 2 shared papers, 2025 · strength 0.32
  11. Naohiro Okano · 2 shared papers, 2025 · strength 0.32
  12. Toshifumi Doi · 2 shared papers, 2025 · strength 0.32
  13. Reiko Ashida · 2 shared papers, 2025 · strength 0.32
  14. Kohei Nakachi · 2 shared papers, 2025 · strength 0.32
  15. Hiroaki Nagano · 2 shared papers, 2025 · strength 0.32
  16. Yasuyuki Kawamoto · 2 shared papers, 2025 · strength 0.32
  17. Akihiro Ohba · 2 shared papers, 2025 · strength 0.32
  18. Noritoshi Kobayashi · 2 shared papers, 2025 · strength 0.32
  19. Hiroshi Imaoka · 2 shared papers, 2025 · strength 0.32
  20. Hiroshi Ohyama · 2 shared papers, 2025 · strength 0.32
  21. Makoto Ueno · 2 shared papers, 2025 · strength 0.32
  22. Shinya Kawaguchi · 2 shared papers, 2025 · strength 0.32
  23. Chigusa Morizane · 2 shared papers, 2025 · strength 0.32
  24. Motowo Mizuno · 1 shared paper, 2026 · strength 0.26
  25. Yuki Ikeda · 1 shared paper, 2026 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.